Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 16.85
0.00 (0.00%)
Oct 29, 2026, 12:15 PM CST
Neith Market Cap
Neith has a market cap or net worth of 701.87 million as of October 30, 2026. It is the 36,304th most valuable company in the world and the 2,180th biggest in Taiwan. Its market cap has decreased by 37.48% in one year.
Market Cap
701.87M
Enterprise Value
568.40M
Revenue
31.84M
Global Rank
Country Rank
#2,180 Taiwan
PE Ratio
2,166.37
ChartMarket Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 701.87M, an increase of 45.08%. That is a compound annual growth rate of 1.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 701.87M | -21.81% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 946.69M |
| Enimmune | 918.00M |
| MegaPro Biomedical | 906.09M |
| Meribank Biotech | 863.78M |
| Lukas Biomedical | 774.68M |
| NatureWise Biotech & Medicals | 765.61M |
| BioLASCO Taiwan | 726.10M |
| Taiwan Advance Bio-Pharmaceutical | 672.30M |